Citation Impact
Citing Papers
Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component
1991
Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease
1989
Vaccine strategies against Epstein‐Barr virus‐associated diseases: lessons from studies on cytotoxic T‐cell‐mediated immune regulation
1999
Impaired Long‐term T Cell Immunity to Epstein‐Barr Virus in Patients with Nasopharyngeal Carcinoma
1992
Community effects and related phenomena in development
1993 StandoutNobel
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
1997 StandoutNobel
The genetics of intervertebral disc degeneration.Familial predisposition and heritability estimation
2008
Involvement of Brca2 in DNA Repair
1998 StandoutNobel
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Cytotoxic T Cells and Human Herpes Virus Infections
1994
Viral latency and transformation: The strategy of Epstein-Barr virus
1989
Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes
1998
Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses
1998 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
2012 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein‐Barr virus
1992
Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing
1997
Regressing nude mouse grafts of burkitt's lymphoma×lymphoblastoid cell hybrids show deregulation of the c‐myc gene and expression of the EBV latent membrane protein
1991 StandoutNobel
Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase
2009 StandoutNobel
Immunological responses to Epstein-barr virus infection and the pathogenesis of EBV-induced diseases
1989
The epstein‐barr‐virus‐encoded membrane protein LMP but not the nuclear antigen EBNA‐1 induces rejection of transfected murine mammary carcinoma cells
1991
Degradation of the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) by the Ubiquitin-Proteasome Pathway
2000 StandoutNobel
Epstein‐barr virus‐infected b cells persist in the circulation of acyclovir‐treated virus carriers
1989
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an igh/myc translocation‐carrying be line
1989
Non-specific low back pain
2011 Standout
A novel form of Epstein-Barr virus latency in normal B cells in vivo
1995 Standout
Epstein–Barr Virus Infection
2000 Standout
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1
1997 StandoutNobel
Fluorescent light-induced DNA crosslinkage and chromatid breaks in mouse cells in culture.
1978 StandoutNobel
Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage
1999 StandoutNobel
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
2001 StandoutNobel
Conditions Determining Initiation of DNA Synthesis in 3T3 Cells
1970 StandoutNobel
Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is
1975 Standout
Diphtheria Toxin-dependent Adenosine Diphosphate Ribosylation of Aminoacyl Transferase II and Inhibition of Protein Synthesis
1968 StandoutNobel
Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases
2000
Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
1994 StandoutNobel
Requirement of a Cytoplasmic Fraction for Synthesis of SV40 Deoxyribonucleic Acid in Isolated Nuclei*
1975 StandoutNobel
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.
1983 Standout
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
1999
PINOCYTOSIS IN FIBROBLASTS
1974 StandoutNobel
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells
1976 StandoutNatureNobel
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Behavior of Tissue Culture Cells Infected with Polyoma Virus
1970 StandoutNobel
Malignant Transformation of Cells in Vitro
1965
Cell Transformation by Viruses
1969 StandoutScienceNobel
Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines
2000
HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
1997
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
1992
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
1990
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
2001 StandoutNobel
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Adenosine Diphosphate Ribosylation of Aminoacyl Transferase II and Inhibition of Protein Synthesis by Diphtheria Toxin
1971 StandoutNobel
Chapter 4 Low-Resistance Junctions Between Cells in Embryos and Tissue Culture
1968
Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.
1979 StandoutNobel
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
1992
The effect of 4-aminopyrazolo(3,4-d)pyrimidine and guanine on ehrlich ascites cells in culture
1967
Epitope Landscape in Breast and Colorectal Cancer
2008 StandoutNobel
Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1
2004
Viral DNA in polyoma- and SV40-transformed cell lines.
1968 StandoutNobel
Viruses in Human Cancers
1991 StandoutScienceNobel
Induction of virus multiplication in 3T3 cells transformed by a thermosensitive mutant of polyoma virus
1970 StandoutNobel
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma
1975 Standout
AN EARLY EFFECT OF DIPHTHERIA TOXIN ON THE METABOLISM OF MAMMALIAN CELLS GROWING IN CULTURE
1960
Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers
2003
RBP-L, a Transcription Factor Related to RBP-Jκ
1997 StandoutNobel
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
1996 StandoutNobel
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus
1989
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Topoinhibition and Serum Requirement of Transformed and Untransformed Cells
1970 StandoutNatureNobel
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
1989
QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES
1963 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen
1992
Production of SV40 virus in heterokaryons of transformed and susceptible cells.
1967 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Richard E. McCarthy being referenced
Isolation and serial propagation of malignant and normal cells in semi-defined media. Origins of CCRF cell lines.
1960
Tibial length following intraosseous infusion: A prospective, radiographic analysis
1997
Trends in Adolescent Lumbar Disk Herniation
2006
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants
1988 Nature